GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,383.00 GBX | +2.90% |
|
+3.09% | -4.63% |
| Dec. 09 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
| Dec. 09 | Sector Update: Health Care | MT |
Chart calendar GSK plc
2547e0a3a.iLsX1Q-99u2GTYlUt9l86XjYxsW3B5Euas05eSK1e4o.ysJ85kP7nrnSLs431ohFqAmU_oTYQtZ-Av4NAFHmDbzG-HmDQtWPoMMjwA~dcebbe62660f5d8ef5000a74a248f89e
Upcoming events on GSK plc
Past events on GSK plc
| 2024-12-04 | Citi Global Healthcare Conference |
| 2024-12-04 07:00 am | Redburn CEO Conference |
| 2024-12-03 | Evercore ISI HealthCONx Conference |
| 2024-11-26 | Bernstein Premium Review Conference |
| 2024-11-19 08:30 am | JP Morgan UK Leaders Conference |
| 2024-11-19 05:30 am | Jefferies London Healthcare Conference |
| 2024-11-18 08:05 am | ICR Consilium Healthcare Conference - Panel |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:4286 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:1381 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:1201 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:4501 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:4290 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:1078 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:4288 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:4311 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:2289 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:4285 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:1295 |
| 2024-11-14 | American Association for the Study of Liver Disease Meeting - Poster No:1326 |
| 2024-11-13 | Détachement de for dividende intermédiaire |
Past dividends on GSK plc
| 2024-11-13 | Interim Payment 0.15 GBP |
| 2024-08-14 | Interim Payment 0.15 GBP |
| 2024-05-15 | Interim Payment 0.15 GBP |
| 2024-02-21 | Final Payment 0.16 GBP |
| 2023-11-15 | Interim Payment 0.14 GBP |
| 2023-08-16 | Interim Payment 0.14 GBP |
| 2023-05-17 | Interim Payment 0.14 GBP |
| 2023-02-22 | Final Payment 0.1375 GBP |
| 2022-11-16 | Interim Payment 0.1375 GBP |
| 2022-08-17 | Interim Payment 0.1625 GBP |
| 2022-05-18 | Interim Payment 0.14 GBP |
| 2022-02-23 | Final Payment 0.23 GBP |
| 2021-11-17 | Interim Payment 0.19 GBP |
| 2021-08-18 | Interim Payment 0.19 GBP |
| 2021-05-19 | Interim Payment 0.19 GBP |
| 2021-02-17 | Final Payment 0.23 GBP |
| 2020-11-11 | Interim Payment 0.19 GBP |
| 2020-08-12 | Interim Payment 0.19 GBP |
| 2020-05-13 | Interim Payment 0.19 GBP |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 34 114 34 029 0.25% | 29 324 29 105 0.75% | 30 328 29 850 1.6% | 31 169 | 32 317 | 34 216 |
|
EBITDA Million GBP | Released Forecast Spread | 11 330 10 048 12.76% | 10 449 9 257 12.88% | 11 635 10 203 14.04% | 10 222 | 11 121 | 12 272 |
|
EBIT Million GBP | Released Forecast Spread | 8 806 8 717 1.02% | 8 151 7 952 2.5% | 8 786 8 780 0.07% | 9 004 | 9 557 | 10 722 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 5 442 5 794 -6.07% | 5 628 5 548 1.45% | 6 064 7 498 -19.12% | 4 827 | 7 929 | 9 196 |
|
Net income Million GBP | Released Forecast Spread | 4 385 3 990 9.91% | 14 956 6 238 139.74% | 4 928 5 481 -10.09% | 3 674 | 5 807 | 6 587 |
|
EPS GBP | Released Forecast Spread | 1,08 1,02 6.28% | 3,66 1,66 120.52% | 1,22 1,38 -11.61% | 0,90 | 1,41 | 1,60 |
| Announcement Date | 09/02/22 | 01/02/23 | 31/01/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 6 951 6 580 5.64% | 7 178 6 795 5.63% | 8 147 7 727 5.43% | 8 052 7 621 5.65% | 7 363 7 060 4.3% | 7 884 7 493 5.21% | 8 012 8 007 0.06% | 7 644 |
|
EBITDA Million GBP | Released Forecast Spread | 2 732 2 418 12.97% | 2 622 2 506 4.64% | 3 351 3 072 9.09% | 2 930 2 094 39.93% | 2 992 2 406 24.36% | 3 152 2 502 25.98% | 3 712 2 788 33.12% | 1 731 |
|
EBIT Million GBP | Released Forecast Spread | 2 092 1 930 8.42% | 2 170 1 999 8.56% | 2 772 2 570 7.88% | 1 752 1 836 -4.58% | 2 443 2 099 16.38% | 2 513 2 205 13.97% | 2 761 2 463 12.1% | 1 347 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 1 907 1 529 24.72% | 1 987 1 500 32.51% | 1 791 2 225 -19.51% | 379 1 361 -72.15% | 1 355 1 696 -20.11% | 1 495 1 818 -17.77% | 64,0 2 023 -96.84% | 948 |
|
Net income Million GBP | Released Forecast Spread | 1 490 1 179 26.41% | 1 624 1 213 33.86% | 1 464 1 739 -15.79% | 350 834 -58.04% | 1 046 1 297 -19.32% | 1 173 1 386 -15.4% | -58,0 623 -109.31% | 802 |
|
EPS GBP | Released Forecast Spread | 0,37 0,29 27.52% | 0,40 0,30 35.52% | 0,36 0,43 -15.26% | 0,09 0,20 -58.02% | 0,25 0,31 -19.17% | 0,29 0,34 -15.05% | -0,01 0,15 -109.28% | 0,19 |
| Announcement Date | 26/04/23 | 26/07/23 | 01/11/23 | 31/01/24 | 01/05/24 | 31/07/24 | 30/10/24 | - |
More events
Past sector events for GSK plc
| 2024-12-08 07:01 pm | BORA PHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-12-04 02:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-11-28 | DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release |
| 2024-11-15 01:38 am | BAVARIAN NORDIC A/S: Q3 2024 Earnings Release |
| 2024-11-14 11:01 pm | CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release |
| 2024-11-14 09:03 am | GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release |
| 2024-11-14 07:00 am | OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release |
| 2024-11-14 02:49 am | IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release |
| 2024-11-14 01:30 am | DERMAPHARM HOLDING SE: Q3 2024 Earnings Release |
| 2024-11-14 01:30 am | ALK-ABELLÓ A/S: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GSK Stock
- Calendar GSK plc